In a cohort of 64 NSCLC patients, 45 of whom had undergone surgery and 19 that had received only chemotherapy, Helios was expressed in 47.5 ± 13.3% in peripheral blood and 18.1 ± 13.4% of tumor-infiltrating Tregs. This evidence concerns the gene IKZF2 and neoplasm.